Home>
Stocks>
Chandra Bhagat Pharma Ltd

Chandra Bhagat Pharma Ltd Share Price (542934)

₹102.020%

Get free price alerts. Set up your Free investment account to get Live Prices. >

Overview

Fundamentals

Technicals

News and Events

Chandra Bhagat Pharma Ltd share Performance

₹102
₹114.99
₹102.02
0.02%
Low
Day's Volatility:12.73%
High
12.71%
₹80
₹160
₹102.02
21.58%
Low
52 Weeks Volatility:78.42%
High
56.83%

Returns %
1 Month Return	7.28 %
3 Month Return	-26.05 %
1 Year Return	-10.51 %

Market Stats
Previous Close	₹102.02
Open	₹114.99
Volume	40.00K
Upper Circuit	-
Lower Circuit	-
Market Cap	₹76.97Cr

Company Information

Chandra Bhagat Pharma Limited was established in Mumbai in 2003, with the mission of providing lifesaving medicines in India. The company's growth is attributed to it's founders Late Shree Chandravadan Bhagat and his son, Mr. Hemant Bhagat, who put in a combined experience of 41 years in pharmaceutical products, bulk drugs and vaccines. Mr Hemant's son, Mr. Pranav Bhagat, joined the business in 2004 and expanded the presence of the company to domestic and international markets. The growth of the company since its inception is taken care by the promoters with progressive thinking and a strong value system. The company is focussed on providing pharmaceuticals and special chemicals products, while striving to become an integrated pharmaceutical company globally.

Share Price: ₹102.02 per share as on 17 Apr, 2024 02:04 AM
Market Capitalisation: ₹76.97Cr as of today
Listing date: 01 Jan, 0001
Chairperson Name: Hemant C Bhagat

Organisation	Chandra Bhagat Pharma Ltd
Headquarters
Industry	Trading
E-voting on shares	Click here to vote

Fundamentals of Chandra Bhagat Pharma Ltd

Insights on Chandra Bhagat Pharma Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Promoter Holding Up
Promoters have increased holdings from 68.24% to 68.69% in Sep 2023 quarter
POSITIVE IMPACT
FII Holding Up
Foreign Institutions have increased holdings from 0.85% to 1.33% in Sep 2023 quarter
NO EFFECT
Against Peers
In the last 1 year, Sun Pharmaceuticals Industries Ltd has given 54.0% return, outperforming this stock by 64.5%
NO EFFECT
Against Peers
In the last 3 years, Sun Pharmaceuticals Industries Ltd has given 140.0% return, outperforming this stock by 20.6%
NEGATIVE IMPACT
Price Dip
In the last 7 days, stock has moved down by -11.1%
NEGATIVE IMPACT
Retail Holding Down
Retail Investor have decreased holdings from 30.91% to 29.09% in Sep 2023 quarter